Exchange: NASDAQ·Updated 07:30 PM EST

About COYA

About

Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing proprietary new therapies to enhance the function of regulatory T cells. Its pipeline includes Treg Modifying Biologics, Allogeneic Treg-Derived Exosomes, and Autologous Treg Cell Therapy. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
8

Frequently Asked Questions

Advertisement|Remove ads.